Sinco Pharmaceuticals Holdings 6833.HK · HKD

Its shares trade on HKEX under the ticker 6833.HK. It has been listed since 10 March 2016. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.08bn and net income of CN¥34.9m. At that date it held total assets of CN¥1.85bn and shareholders' equity of CN¥694.4m.

Sinco Pharmaceuticals Holdings Ltd. engages in the marketing, promotion, and channel management services for pharmaceutical products and medical devices. The company is headquartered in Chengdu, Sichuan. The company went IPO on 2016-03-10. The company provides its integrated MPCM services to small- and medium-sized overseas pharmaceutical manufacturers that do not possess independent marketing and promotion capabilities in China. Its major product is human albumin solution, a human albumin product manufactured by Octapharma, which is used to remedy hypovolemia and hypovolemic shock, abnormally high intracranial pressure, edema and ascites, and to prevent and cure hypoalbuminemia and neonatal hyper-bilirubinemia. In addition, its products include axetine, medocef, esafosfina, tad and taurolite.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Xiangbin HuangExecutive Chairman of the Board, since 2015CN¥2.4m
• Mr. Min JinChief Executive Officer
• Mr. Zhijian HuangExecutive Vice Chairman of the Board, since 2024
• Mr. Yifan LiChief Financial Officer
• Mr. Shifeng LeiExecutive Director, since 2023
• Mr. Tao ZhangGeneral Manager of Sichuan Sinco Pharmaceuticals Company Limited
• Ms. Yunlu PengCompany Secretary
• Mr. Zhizhong BaiLead Non-Executive Independent DirectorCN¥183,000
• Ms. Huan JingNon-Executive Director
• Mr. Ying Kit LauNon-Executive Independent DirectorCN¥183,000
• Prof. Wenfang LiuNon-Executive Independent DirectorCN¥183,000
• Mr. Qing WangNon-Executive Independent DirectorCN¥183,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.